Patents-Review.com
ClassID:

96522 ⎘

C07J17/00 - CPC Classification

Classification description:

Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton

Sub-classes:
Recent Application in this class:
#1
20260125416
2026-05-07

OXYSTEROLS AND METHODS OF USE THEREOF

 #2
20250179112
2025-06-05

OXYSTEROLS AND METHODS OF USE THEREOF

 #3
20250042934
2025-02-06

COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS

 #4
20240368214
2024-11-07

POSITIVE NMDA-MODULATING COMPOUNDS AND METHODS OF USE THEREOF

 #5
20240270784
2024-08-15

OXYSTEROLS AND METHODS OF USE THEREOF

 #6
20240218011
2024-07-04

GLUCOCORTICOID RECEPTOR AGONISTS AND CONJUGATES THEREOF

 #7
20240199682
2024-06-20

OXYSTEROLS AND METHODS OF USE THEREOF

 #8
20240132535
2024-04-25

OXYSTEROLS AND METHODS OF USE THEREOF

 #9
20230391816
2023-12-07

NEUROACTIVE STEROIDS, COMPOSITIONS AND USES THEREOF

 #10
20230382945
2023-11-30

THERAPEUTIC AGENTS AND METHODS

 #11
20230331768
2023-10-19

Oxysterols and methods of use thereof

 #12
20230279043
2023-09-07

Compositions and methods for treating CNS disorders

 #13
20230142627
2023-05-11

Pharmaceutical compositions and methods

 #14
20230118577
2023-04-20

NEUROACTIVE STEROIDS AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME

 #15
20230116347
2023-04-13

C17, C20, AND C21 SUBSTITUTED NEUROACTIVE STEROIDS AND THEIR METHODS OF USE

 #16
20230103142
2023-03-30

SMALL MOLECULE REGULATORS OF NOTCH1 AND USES THEREOF

 #17
20230096870
2023-03-30

INHIBITORS OF GLUCOCORTICOID RECEPTOR

 #18
20220402965
2022-12-22

STEROL ANALOGS AND USES THEREOF

 #19
20220339164
2022-10-27

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS

 #20
20220306680
2022-09-29

Glucocorticoid receptor agonists

 #21
20220298203
2022-09-22

Therapeutic agents and methods

 #22
20220177511
2022-06-09

SERIES OF HALOGENATED TETRACYCLIC TRITERPENE DERIVATIVES AND THEIR PREPARATION AND APPLICATION

 #23
20220169673
2022-06-02

LIPIDIC ANALOGS OF ANTI-CANCER STEM CELL AGENT

 #24
20220079957
2022-03-17

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS

 #25
20220048943
2022-02-17

Oxysterols and methods of use thereof

 #26
20220024968
2022-01-27

Oxysterols and methods of use thereof

 #27
20210403502
2021-12-30

Neuroactive steroids, compositions, and uses thereof

 #28
20210388020
2021-12-16

Process for the preparation of 3α-hydroxy-5α-pregnan-20-one (brexanolone)

 #29
20210380631
2021-12-09

Oxysterols and methods of use thereof

 #30
20210361675
2021-11-25

System and method for diagnosis and treatment

 #31
20210347810
2021-11-11

STEROL PURIFICATION

 #32
20210261598
2021-08-26

Oxysterols and methods of use thereof

 #33
20210179661
2021-06-17

Intermediates for the synthesis of bile acid derivatives, in particular of obeticholic acid

 #34
20210179660
2021-06-17

GLUCOCORTICOID INHIBITORS FOR TREATMENT OF PROSTATE CANCER

 #35
20210113593
2021-04-22

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS

 #36
20210094981
2021-04-01

Neuroactive steroids, compositions, and uses thereof

 #37
20210024572
2021-01-28

Hydroxysteroid compounds, their intermediates, process of preparation, composition and uses thereof

 #38
20210017219
2021-01-21

INHIBITORS OF GLUCOCORTICOID RECEPTOR

 #39
20210017218
2021-01-21

COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS

 #40
20210008080
2021-01-14

System and method for diagnosis and treatment

 #41
20210002324
2021-01-07

Inhibitors of glucocorticoid receptor

 #42
20200291058
2020-09-17

Inhibitors of glucocorticoid receptor

 #43
20200190134
2020-06-18

Compounds and methods of making sterols using diols

 #44
20200123195
2020-04-23

Oxysterols and methods of use thereof

 #45
20200101087
2020-04-02

Pharmaceutical compositions and methods

 #46
20200087338
2020-03-19

NUCLEOTIDE AND OLIGONUCLEOTIDE PRODRUGS

 #47
20200085846
2020-03-19

Certain chemical entities, compositions, and methods

 #48
20200071351
2020-03-05

TACCALONOLIDE MICROTUBULE STABILIZERS

 #49
20200055892
2020-02-20

Inhibitors of glucocorticoid receptor

 #50
20200016178
2020-01-16

19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof

 #51
20190365786
2019-12-05

PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE OF 4-PREGENEN-11BETA-17-21-TRIOL-3,20-DIONE DERIVATIVES

 #52
20190330259
2019-10-31

OXYSTEROLS AND METHODS OF USE THEREOF

 #53
20190309012
2019-10-10

Process and intermediates for the 6,7-alpha-epoxidation of steroid 4,6-dienes

 #54
20190284227
2019-09-19

Intermediates for the synthesis of bile acid derivatives, in particular of obeticholic acid

 #55
20190269701
2019-09-05

Oxysterol-statin compounds for bone growth

 #56
20190256549
2019-08-22

Panaxdiol-type ginsenoside derivative, preparation method therefor and use thereof

 #57
20190248831
2019-08-15

C17, C20, and C21 substituted neuroactive steroids and their methods of use

 #58
20190248829
2019-08-15

Oxysterols and methods of use thereof

 #59
20190224218
2019-07-25

Certain chemical entities, compositions, and methods

 #60
20190185512
2019-06-20

Compounds and methods of making sterols using diols

 #61
20190169226
2019-06-06

Neuroactive steroids, compositions, and uses thereof

 #62
20190151335
2019-05-23

System and method for diagnosis and treatment

 #63
20190134062
2019-05-09

Pharmaceutical compositions and methods

 #64
20190085019
2019-03-21

Raman tag

 #65
20190062367
2019-02-28

Methods for the preparation of obeticholic acid and derivatives thereof

 #66
20190046543
2019-02-14

Method of sensitizing cancer cells to the cytotoxic effects of apoptosis inducing ligands in cancer treatment

 #67
20190002492
2019-01-03

DERIVATIVES OF ALLOPREGNANOLONE AND OF EPIALLOPREGNANOLONE AND USES THEREOF FOR TREATING A NEUROPATHOLOGICAL CONDITION

 #68
20180360852
2018-12-20

System and method for diagnosis and treatment

 #69
20180333424
2018-11-22

Oxysterol-statin compounds for bone growth

 #70
20180327444
2018-11-15

Chemical compounds and use thereof for improving muscular quality

 #71
20180325920
2018-11-15

System and Method for Diagnosis and Treatment

 #72
20180320212
2018-11-08

Method for selectively producing ginsenoside Rd from saponins of ginseng through enzymatic method

 #73
20180312894
2018-11-01

Method for selectively producing compound K and compound Y from saponins of ginseng through enzymatic method

 #74
20180280413
2018-10-04

Compositions and Methods For Increasing Telomerase Activity

 #75
20180273574
2018-09-27

Nucleotide and oligonucleotide prodrugs

 #76
20180194797
2018-07-12

Oxysterols and methods of use thereof

 #77
20180185392
2018-07-05

Pharmaceutical compositions and methods

 #78
20180162900
2018-06-14

Polymorphic forms of an oxysterol and methods of making them

 #79
20180147217
2018-05-31

Pharmaceutical compositions and methods of use of 4-pregenen-11β-17-21-triol-3,20-dione derivatives

 #80
20180141971
2018-05-24

19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof

 #81
20180125866
2018-05-10

Certain chemical entities, compositions, and methods

 #82
20170342102
2017-11-30

Compositions and methods for treating CNS disorders

 #83
20170327529
2017-11-16

20(R)-ginsenoside Rg3 polyacylated derivatives, preparation and application thereof

 #84
20170313738
2017-11-02

Raman tag

 #85
20170292945
2017-10-12

Method for screening activator of mitochondrial activity

 #86
20170267711
2017-09-21

Compounds and methods of making sterols using diols

 #87
20170247406
2017-08-31

Neuroactive steroids, compositions, and uses thereof

 #88
20170218009
2017-08-03

Compounds for treating eye disorders or diseases

 #89
20170204132
2017-07-20

Compounds and methods involving sterols

 #90
20170197912
2017-07-13

Synthesizing pet tracers using [F-18]sulfonyl fluoride as a source of [F-18]fluoride

 #91
20170182062
2017-06-29

4-pregenen-11β-17-21-triol-3,20-dione derivatives

 #92
20170158730
2017-06-08

Hydroxysteroid compounds, their intermediates, process of preparation, composition and uses thereof

 #93
20170146533
2017-05-25

Compounds comprising one or more hydrophobic domains and a hydrophilic domain comprising peg moieties, useful for binding cells

 #94
20170051007
2017-02-23

Pharmaceutical compositions and methods

 #95
20170020897
2017-01-26

Certain chemical entities, compositions, and methods

 #96
20160362375
2016-12-15

Iodine(II)-mediated radiofluorination

 #97
20160318973
2016-11-03

Compositions and methods for increasing telomerase activity

 #98
20160289261
2016-10-06

Glucocorticoid inhibitors for treatment of prostate cancer

 #99
20160279149
2016-09-29

System and method for diagnosis and treatment

 #100
20160279148
2016-09-29

System and method for diagnosis and treatment

 #101
20160251392
2016-09-01

5-β, 14-β-androstane derivatives useful for the treatment of proteinuria, glomerulosclerosis and renal failure

 #102
20160229885
2016-08-11

Process for the preparation of estetrol

 #103
20160159852
2016-06-09

Combination of estrogens plus antiprogestins with significant partial agonistic effect as an effective treatment of menopausal symptoms and for prevention of the occurrence of breast cancer

 #104
20160159849
2016-06-09

Compounds and methods of making sterols using diols

 #105
20160159848
2016-06-09

Compounds and methods involving sterols

 #106
20160145296
2016-05-26

Bile acid analogs as FXR/TGR5 agonists and methods of use thereof

 #107
20160083417
2016-03-24

19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof

 #108
20160068562
2016-03-10

Raman tag

 #109
20160060287
2016-03-03

Nucleotide and oligonucleotide prodrugs

 #110
20150376225
2015-12-31

NOVEL COMPOUNDS OF 11BETA-HYDROXY-STEROIDS FOR USE IN MITOCHONDRIA BIOGENESIS AND DISEASES ASSOCIATED WITH MITOCHONDRIAL DYSFUNCTION OR DEPLETION

 #111
20150368289
2015-12-24

Protopanoxadiol derivative, preparation method thereof and application thereof

 #112
20150366882
2015-12-24

System and method for diagnosis and treatment

 #113
20150338736
2015-11-26

Actinic-ray- or radiation-sensitive resin composition, actinic-ray- or radiation-sensitive film and method of forming pattern

 #114
20150252007
2015-09-10

Iodine(III)-mediated radiofluorination

 #115
20150247090
2015-09-03

Monomer, liquid crystal composition, liquid crystal display device, and production method for liquid crystal display device

 #116
20150246944
2015-09-03

Certain chemical entities, compositions, and methods

 #117
20150086615
2015-03-26

Sterol derivatives and use thereof for treating diseases involving transformed astrocyte cells or for treating malignant haemopathies

 #118
20150065699
2015-03-05

Ginsenoside C-K polymorphic compounds and method for preparing same

 #119
20150057258
2015-02-26

4-pregenen-11β-17-21-triol-3,20-dione derivatives

 #120
20150005519
2015-01-01

Pharmaceutical compositions and methods of use of 4-pregenen-11β-17-21-triol-3,20-dione derivatives

 #121
20140378399
2014-12-25

Vascular leakage inhibitor

 #122
20140315874
2014-10-23

6-substituted demethyl-estradiol derivatives as selective ER-β agonists

 #123
20140200341
2014-07-17

Method for the Production of Fluoromethyl Esters of Androstan-17 beta Carboxylic Acids

 #124
20140107086
2014-04-17

System and method for diagnosis and treatment

 #125
20140088055
2014-03-27

Compositions and methods for increasing telomerase activity

 #126
20140058079
2014-02-27

DERIVATIVES OF ALLOPREGNANOLONE AND OF EPIALLOPREGNANOLONE AND USES THEREOF FOR TREATING A NEUROPATHOLOGICAL CONDITION

 #127
20140056916
2014-02-27

Aldosterone induced vascular elastin production

 #128
20130274461
2013-10-17

Method for preparing fluticasone furoate

 #129
20130184244
2013-07-18

Process for preparing delta-7,9(11) steroids from and analogs thereof

 #130
20130131025
2013-05-23

Hyperlipemia-ameliorating agent, anemia-ameliorating composition, uric-acid-level-reducing composition, and food or beverage

 #131
20130123226
2013-05-16

Pharmaceutical compositions and methods of use 4-pregenen-11β-17-21-triol-3,20-dione derivatives

 #132
20130123224
2013-05-16

Certain chemical entities, compositions, and methods

 #133
20130123223
2013-05-16

4-pregenen-11β-17-21-triol-3,20-dione derivatives

 #134
20130116428
2013-05-09

Poly(ethylene oxide)-block-poly(ester) block copolymers

 #135
20130072698
2013-03-21

Method and Compounds for the Preparation of Monofluoromethylated Biologically Active Organic Compounds

 #136
20130046090
2013-02-21

Cyclisation process of forming a multiple ring compound

 #137
20120309728
2012-12-06

NEW STEROID INHIBITORS OF PGP FOR USE FOR INHIBITING MULTIDRUG RESISTANCE

 #138
20120283217
2012-11-08

MODULATORS OF AMYLOID-BETA PRODUCTION

 #139
20120264709
2012-10-18

Nucleotide and oligonucleotide prodrugs

 #140
20120258184
2012-10-11

HYPERLIPEMIA-AMELIORATING AGENT, ANEMIA-AMELIORATING COMPOSITION, URIC-ACID-LEVEL-REDUCING COMPOSITION, AND FOOD OR BEVERAGE

 #141
20120245110
2012-09-27

Vascular leakage inhibitor

 #142
20120201747
2012-08-09

System and method for diagnosis and treatment

 #143
20120196815
2012-08-02

Withanolide isolated from and analogs and methods of use thereof

 #144
20120190841
2012-07-26

Compound having neurite-outgrowing activity

 #145
20120136142
2012-05-31

Adjuvant

 #146
20120116069
2012-05-10

GLUCOSE METABOLISM-IMPROVING AGENT AND GLUCOSE METABOLISM-IMPROVING COMPOSITION

 #147
20120083592
2012-04-05

CONTINUOUS PREPARATION METHOD OF GINSENG GINSENOSIDES AND POLYSACCHARIDES

 #148
20120071455
2012-03-22

6-SUBSTITUTED DEMETHYL-ESTRADIOL DERIVATIVES AS SELECTIVE ER-BETA AGONISTS

 #149
20120028945
2012-02-02

5-Beta, 14-Beta-Androstane Derivatives Useful For The Treatment Of Proteinuria, Glomerulosclerosis And Renal Failure

 #150
20110280805
2011-11-17

Nurotoxic sterol glycosides

 #151
20110269725
2011-11-03

Estrogenic compounds, pharmaceutical compositions and formulations comprising the same

 #152
20110201584
2011-08-18

Certain chemical entities, compositions, and methods

 #153
20110165176
2011-07-07

Aldosterone induced vascular elastin production

 #154
20110118225
2011-05-19

Ligands of estrogen receptors α and β, method of their preparation, and pharmaceuticals comprising them

 #155
20110091376
2011-04-21

Cationic steroid antimicrobial diagnostic, detection, screening and imaging methods

 #156
20110009615
2011-01-13

METHOD FOR PRODUCING A STEROID COMPOUND

 #157
20110003761
2011-01-06

Biologically active extract from plant, use thereof and process for preparing the same

 #158
20100292197
2010-11-18

Compositions and methods for increasing telomerase activity

 #159
20100256078
2010-10-07

Neoglycorandomization and digitoxin analogs

 #160
20100234330
2010-09-16

Estrogenic compounds and pharmaceutical formulations comprising the same

 #161
20100228058
2010-09-09

Cyclisation process of forming a multiple ring compound

 #162
20100174101
2010-07-08

Process for the manufacture of 7-alpha-[9-(4,4,5,5,5-penta fluoropentylsulphinyl) nonyl]estra-1,3,5-(10)- triene-3,17-beta-diol

 #163
20100144688
2010-06-10

23-Substituted Derivatives of Lupane-type Pentacyclic Triterpenoids

 #164
20100069295
2010-03-18

Poly(ethylene oxide)-block-poly(ester) block copolymers

 #165
20100063272
2010-03-11

METHOD FOR PRODUCING STEROID COMPOUND

 #166
20100062023
2010-03-11

CHOLESTEROL-CONTAINING COMPOUNDS AND THEIR USE AS IMMUNOGENS AGAINST BORRELIA BURGDORFERI

 #167
20100056487
2010-03-04

MODULATORS OF AMYLOID-BETA PRODUCTION

 #168
20100035851
2010-02-11

Agent for improving insulin resistance

 #169
20090105198
2009-04-23

Estrogenic compounds, methods of using and methods of administering the same

 #170
20090088412
2009-04-02

COMPOSITION FOR TREATING CANCER CELLS AND PREPARATION METHOD THEREOF

 #171
20090082318
2009-03-26

DEUTERIUM-ENRICHED MOMETASONE

 #172
20090075842
2009-03-19

Neoglycorandomization and digitoxin analogs

 #173
20090069254
2009-03-12

Agent for inhibiting visceral fat accumulation

 #174
20090062526
2009-03-05

Method of synthesizing alkylated bile acid derivatives

 #175
20090054388
2009-02-26

11β-hydroxyandrosta-4-ene-3-ones

 #176
20090005324
2009-01-01

Biologically active extract from dendrobium plant, use thereof and process for preparing the same

 #177
20080300228
2008-12-04

Crystalline rostafuroxin

 #178
20080166301
2008-07-10

Steroidal antiestrogens and antiandrogens and uses thereof

 #179
20080153034
2008-06-26

Low activation energy dissolution modification agents for photoresist applications

 #180
20080020988
2008-01-24

Brain cell- or nerve cell-protecting agents comprising medicinal ginseng

 #181
20070254859
2007-11-01

Compounds exhibiting efflux inhibitor activity and composition and uses thereof

 #182
20070232578
2007-10-04

Crystalline forms of ciclesonide

 #183
20070231734
2007-10-04

Low activation energy dissolution modification agents for photoresist applications

 #184
20070149462
2007-06-28

Nucleotide and oligonucleotide prodrugs

 #185
20070142631
2007-06-21

Conjugates of mycophenolic acid

 #186
20070142307
2007-06-21

Estrogenic compounds and topical pharmaceutical formulations of the same

 #187
20070099852
2007-05-03

CUCURBITACIN COMPOUNDS

 #188
20070088003
2007-04-19

Asthma associated factors as targets for treating atopic allergies including asthma and related disorders

 #189
20060252948
2006-11-09

Production method of steroid compound

 #190
20060252704
2006-11-09

Polymorphs of 3--(3′,3′-dimethylsuccinyl)betulinic acid di--methyl-D-glucamine

 #191
20060240129
2006-10-26

Skin tissue regeneration promoters comprising ginsenoside Rb1

 #192
20060234956
2006-10-19

Dicarboxylic acid ester derivatives of ginsenoside, pharmaceutical preparations containing the same, and preparation thereof

 #193
20060211857
2006-09-21

6,7-Oxygenated steroids and uses related thereto

 #194
20060205931
2006-09-14

Pharmaceutical compositions having appetite suppressant activity

 #195
20060204515
2006-09-14

Cholesterol-containing compounds and their use as immunogens against

#196
20060193903
2006-08-31

Glycoside-containing liposome

 #197
20060149045
2006-07-06

Steroid compounds with anti-tumor activity

 #198
20060148773
2006-07-06

Novel steroidal antiestrogens and antiandrogens and uses thereof

 #199
20060128950
2006-06-15

Glucuronide metabolites and epimers thereof of tigecycline

 #200
20060116331
2006-06-01

Glycosylceramide analogues

 #201
20060069043
2006-03-30

Chiral separation, characterization and biological action of optically active isomers of digoxin

 #202
20060041109
2006-02-23

Neoglycorandomization and digitoxin analogs

 #203
20060014729
2006-01-19

Compounds and their preparation for the treatment of Alzheimer's disease by inhibiting beta-amyloid peptide production

 #204
20060014704
2006-01-19

Compounds and their preparation for the treatment of Alzheimer's disease by inhibiting beta-amyloid peptide production

 #205
20060009431
2006-01-12

Nitrosated and nitrosylated compounds, compositions and methods use

 #206
20050267051
2005-12-01

Antineoplastic and anti-HIV conjugates of steroid acid and nucleosides

 #207
20050245465
2005-11-03

Compounds for treating Alzheimer's disease and for inhibiting beta-amyloid peptitde production

 #208
20050209445
2005-09-22

Process for producing enriched fractions containing upto 100% of bacoside a and bacoside b from plant materials of bacopa species

 #209
20050209168
2005-09-22

Isolation of tigogenin pentaglycoside from

#210
20050175623
2005-08-11

Saponins as anticancer agent

 #211
20050152845
2005-07-14

Amorphous fluticasone 2-furoate, pharmaceutical compositions thereof and its conversion to the crystalline unsolvated form

 #212
20050070515
2005-03-31

Compounds

 #213
20050054622
2005-03-10

Anti-inflammatory androstane derivatives

 #214
20050053955
2005-03-10

Nucleic acid-based assay and kit for the detection of methanogens in biological samples

 #215
20050043284
2005-02-24

Crystalline complexes of fluticasone-2-furoate

 #216
20050009076
2005-01-13

Conjugates of mycophenolic acid

 #217
12536423
2015-07-21

Facial amphiphiles and methods of use